Planmed announced that effective Nov. 15, 2014, its Planmed Verity extremity computed tomography (CT) scanner is available on the Novation Merry-X-Ray capital equipment and diagnostics imaging distribution contract (XR0262), effective through July 31, 2017.
Kennedy Health has selected Mach7 Technologies’ vendor neutral archive (VNA), Enterprise Imaging Platform and zero-footprint universal Clinical Viewer. The selection caps a year-long intensive vendor evaluation.
Version 6.3.3 of Fujifilm’s Synapse RIS received 2014 Edition Complete EHR certification from the Office of the National Coordinator for Health Information Technology (ONC HIT). The designation indicates that the software is capable of supporting eligible professionals with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
SuperSonic Imagine announced a partnership with U.S.-based Unetixs Vascular Inc. to bring SuperSonic Imagine’s technology to more customers in the vascular market.
At the 2015 European Congress of Radiology (ECR 2015), Esaote introduced Evolution’15 (EVO’15) as the latest upgrade in its dedicated magnetic resonance imaging (MRI) Evolution program. EVO’15 combines software updates and new hardware features to provide high image quality and increases productivity by almost 50 percent.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Physicians treating patients with complex tumors will have more advanced treatment options at Seattle Cancer Care Alliance Proton Therapy, a ProCure Center. The center will now offer pencil beam scanning (PBS) in its state-of-the-art gantry room. The combination of proton therapy with PBS technology enables physicians to better shape and direct radiation to the tumor, opening the doors to treat a wider variety of cancers.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
For the third consecutive year, a Dolbey speech recognition solution was named Best in KLAS. Dolbey earned this year’s Best in KLAS award for its Fusion SpeechEMR front-end speech software. In addition, Dolbey’s back-end speech product, Fusion Speech, earned the 2014 KLAS Category Leader award for the Speech Recognition, Back End category. Dolbey’s Fusion Suite includes speech recognition, dictation, transcription, core measures and coding solutions.
Accuray Inc. and Lancaster General Health announced that the first commercially available InCise multileaf collimator (MLC) for the CyberKnife M6 System has been received by Lancaster. The hospital selected the InCise MLC based on its ability to increase the system's treatment efficiency and extend its unique capabilities to a broader range of patient cases.
A decline in smoking rates may mean that many people who could have benefited from early detection of lung cancer are dying because they don’t qualify for low-dose computed tomography (CT) scans, according to a group of Mayo Clinic researchers. Their research appears in the Feb. 24 issue of JAMA, the journal of the American Medical Association.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Americans are ready and willing to leverage health apps and wearable devices to improve their personal health, according to the findings released from the fifth annual Makovsky/Kelton "Pulse of Online Health" Survey.
Spellman High Voltage Electronics Corp. announced that it has signed an agreement with Power Valley Technologies of Beijing, China, to purchase the commercial assets and technologies of their power conversion group.
Together with physicians, other research groups, and industry partners, Fraunhofer MEVIS is developing software to optimize radiation therapy. The fifth clinical workshop to evaluate this software took place in Bremen on Feb. 5-6.
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
Researchers at the University of California Los Angeles (UCLA) have found that radiation therapy is the most common treatment for men with prostate cancer regardless of the aggressiveness of the tumor, risk to the patient and overall patient prognosis. These findings lay the groundwork for improved treatment assessment by physicians and to better inform men fighting the disease.
New research from Johns Hopkins School of Medicine reveals a high value for scans which could lead to future change of reimbursement policies for follow-up positron emission tomography/computed tomography (PET/CT) studies in lung cancer. The study, featured in the February 2015 issue of The Journal of Nuclear Medicine, establishes the value of fourth and subsequent follow-up PET/CT scans in clinical assessment and management change in patients with the disease.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Pie Medical Imaging BV announced that it received 510(k) clearance from the U.S. Food and Drug Administration for its CAAS A-Valve product including the quantitative Regurgitation Analysis (qRA) workflow. The qRA workflow is the first 510(k) cleared image analysis technology to determine aortic regurgitation based on X-ray angiography.
Agfa Healthcare announced the commercial launch of its Enterprise Imaging for Cardiology Suite and strategic relationship with TomTec to provide a unified cardiology diagnostic and clinical imaging solution. The solution will be on display at the American College of Cardiology (ACC) 2015 meeting, March 14-16, 2015 in San Diego.
A pilot study led by researchers at Joslin Diabetes Center has revealed that it is possible to use magnetic resonance imaging (MRI) to "see" the inflammation in the pancreas that leads to type 1 diabetes. This discovery could be a boon for research on methods to slow or halt the disease at an early stage, and could also guide insights into how diabetes progresses.
The Mevion S250 proton therapy system has become the first proton therapy system to receive a medical device license from Health Canada, the federal department responsible for public health, and is now approved to be installed at cancer facilities across the country.
Mobius Medical Systems LP announced the release of Mobius3D version 1.5. For users with the MobiusFX treatment verification module, the newest version of Mobius3D automatically verifies accurate delivery of every fraction in a patient’s course of treatment.
A recently completed National Institutes of Health-funded trial confirms the efficacy of blood flow measurement technology from VasSol Inc. to predict the possibility of repeated stroke in at-risk individuals.